Global Healthcare Analytical Testing Services Market Size to worth USD 32.73 Billion by 2033: Forecast Analysis Report

RELEASE DATE: Mar 2025 Author: Spherical Insights
The Global Healthcare Analytical Testing Services Market Size is Expected to Grow from USD 14.51 Billion in 2023 to USD 32.73 Billion by 2033, at a CAGR of 8.47% during the forecast period 2023-2033.

Table of Contents

Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis


Related Topics

Aviation IoT Market Size Pharmaceutical Impurity Synthesis and Isolation Services Market Size Inhaled Nitric Oxide Delivery Systems Market Size Adhesives and Sealants Market Size

Global Healthcare Analytical Testing Services Market Size to worth USD 32.73 Billion by 2033

According to a research report published by Spherical Insights & Consulting, the Global Healthcare Analytical Testing Services Market Size is Expected to Grow from USD 14.51 Billion in 2023 to USD 32.73 Billion by 2033, at a CAGR of 8.47% during the forecast period 2023-2033. 

 

Browse key industry insights spread across 210 pages with 110 Market data tables and figures & charts from the report on the Global Healthcare Analytical Testing Services Market Size, Share, and COVID-19 Impact Analysis, By Type (Biomarker Testing, Stability Testing, Raw Material Testing, Batch-release Testing, and Cleaning Validation), By End User (Pharmaceutical Companies and Medical Device Companies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033. 

     

Healthcare analytical testing services involve a wide range of scientific techniques used to evaluate the quality, safety, and efficacy of healthcare products, including pharmaceuticals, biologics, medical devices, and diagnostics. These services are crucial for ensuring compliance with regulatory requirements and maintaining product integrity throughout development, manufacturing, and distribution. Analytical testing includes different methodologies like chemical analysis, microbiological testing, and stability studies concerning evaluating raw materials, finished products, and environmental conditions. These services are very critical in the healthcare industry for validating the fact that the product has satisfied stringent quality standards, and supporting regulatory submissions for approvals across different global markets. Furthermore, the growth of the healthcare analytical testing services market is driven by the increasing demand for high-quality healthcare products and the rising need for compliance with regulatory standards set by authorities such as the FDA, EMA, and ICH. Expanding research and development activities, particularly in biologics and personalized medicine, further contribute to the market's expansion. The growing healthcare infrastructure in emerging markets and the increasing focus on patient safety and efficacy also play significant roles in driving the demand for these services. However, high costs associated with advanced testing technologies and the complexity of regulatory requirements may limit market growth.

 

The biomarker testing segment is predicted to hold the greatest market share through the forecast period.

Based on the type, the healthcare analytical testing services market is classified into biomarker testing, stability testing, raw material testing, batch-release testing, and cleaning validation. Among these, the biomarker testing segment is predicted to hold the greatest market share through the forecast period. This is primarily due to the increasing focus on personalized medicine and the growing need for precise diagnostic tools to tailor treatments to individual patients. Biomarker testing plays a crucial role in the development of targeted therapies, particularly in oncology, neurology, and immunology, by identifying specific biological markers that indicate disease presence, progression, or response to treatment.

 

The pharmaceutical companies segment is anticipated to hold the greatest market share during the projected timeframe.    

Based on the end user, the healthcare analytical testing services market is divided into pharmaceutical companies and medical device companies. Among these, the pharmaceutical companies segment is anticipated to hold the greatest market share during the projected timeframe. This is largely because the pharmaceutical industry applies the most extensive use of analytical testing services in developing, manufacturing, and regulatory compliance. Analytical testing is largely used by pharmaceutical companies for preclinical and clinical testing, as well as stability, raw material, and batch-release testing to ensure the quality and efficacy of drugs.

 

North America is estimated to hold the largest healthcare analytical testing services market share over the forecast period.

North America is estimated to hold the largest healthcare analytical testing services market share over the forecast period. Most pharmaceutical and medical device businesses in the U.S. conduct most of their business in this region. This market is expected to grow because the region houses some of the top manufacturing facilities, supplying complex, highly reliable, high-end pharmaceuticals & medical device products. Besides that, the growing interest in consumer safety and rising standards for highly regulated drug product processes to meet health requirements push the market demand.

 

Asia-Pacific is predicted to have the fastest CAGR growth in the healthcare analytical testing services market over the forecast period. This has included increasing investments by companies from developed economies to improve regional analytical services, regulatory body amendments aimed at revising the assessment criteria to the global benchmark levels, and new facilities & alliances set up for further widening their products' presence into several regional geographies.

 

Competitive Analysis

Major key players in the healthcare analytical testing services market are Thermo Fisher Scientific, Inc., ICON plc, LabCorp, Charles River Laboratories International, Inc., Syneos Health, SGS SA, Eurofins Scientific, Pace Analytical Services, LLC, Toxikon, Inc., and Intertek Group.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Development

  • In January 2024, Kindeva Drug Delivery expanded its analytical services, with the launch of a business unit offering integrated & stand-alone analytical support to the wider pharmaceutical, biopharmaceutical, and medical device industry.

 

Market Segment

This study forecasts global, regional, and country revenue from 2023 to 2033. Spherical Insights has segmented the healthcare analytical testing services market based on the below-mentioned segments:

 

Global Healthcare Analytical Testing Services Market, By Type

  • Biomarker Testing
  • Stability Testing
  • Raw Material Testing
  • Batch-release Testing
  • Cleaning Validation

 

Global Healthcare Analytical Testing Services Market, By End User

  • Pharmaceutical Companies
  • Medical Device Companies

 

Global Healthcare Analytical Testing Services Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Recent Insights


Your personal details are safe with us, Privacy Policy.

Thank You!

We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.

+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com

We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies